Key result
LMNA p.Gln310Arg variant linked to altered lamin distribution, increased ROS, and a hypertrophy-like cellular phenotype.
Why the study?
Variants in LMNA are established causes of inherited DCM, but the clinical significance of many rare missense variants remains uncertain.
Case Report (n=1)
No
The LMNA c.929 A > G (p.Gln310Arg) variant induces altered lamin A/C distribution, oxidative stress, and a hypertrophy-like phenotype in vitro, providing preliminary functional evidence for its role in dilated cardiomyopathy.
LMNA p.Gln310Arg induces cellular stress in vitro; hypothesis-generating for dilated cardiomyopathy and should not yet change practice.
Background Variants in LMNA are established causes of inherited dilated cardiomyopathy (DCM); however, the clinical significance of many rare missense variants remains uncertain. We identified the rare LMNA c.929 A > G (p.Gln310Arg) variant in a patient with progressive DCM and performed preliminary variant-specific functional characterization in an AC16 transient overexpression model. Methods Duo whole-exome sequencing and copy-number variation analysis were performed in the proband and his son. Wild-type and p.Gln310Arg lamin A expression constructs were transiently transfected into AC16 cells. Flag-tagged protein expression, Flag-based transfection efficiency, and lamin A/C distribution were assessed by western blotting and immunofluorescence staining. Mitochondrial membrane potential and intracellular ROS-associated fluorescence were assessed using JC-1 and DCFH-DA staining, respectively. ERK1/2, JNK, and p38 MAPK phosphorylation was evaluated by western blotting. Hypertrophy-associated NPPA and NPPB expression was measured by RT-qPCR, and cell area was quantified after phalloidin staining. Results The LMNA c.929 A > G variant was classified as a variant of uncertain significance. Wild-type and p.Gln310Arg lamin A constructs showed comparable Flag-tagged protein expression and Flag-based transfection efficiency. Expression of p.Gln310Arg lamin A was associated with an increased proportion of cells displaying ring-like lamin A/C staining patterns. Variant-expressing cells showed increased intracellular DCF fluorescence, reduced JC-1 red-to-green fluorescence ratio, and selectively increased ERK1/2 phosphorylation, whereas no significant changes were detected in JNK or p38 MAPK phosphorylation. The same cells also showed a hypertrophy-like phenotype characterized by increased NPPA and NPPB expression and enlarged cell area. Conclusion In an AC16 transient overexpression model, expression of p.Gln310Arg lamin A was associated with altered lamin A/C distribution, increased intracellular ROS-associated fluorescence, reduced mitochondrial membrane potential, selectively increased ERK1/2 phosphorylation, and a hypertrophy-like cellular phenotype. These findings provide preliminary variant-specific functional evidence but do not establish the pathogenicity of the variant or the causal relationships among the observed cellular abnormalities. Further validation in endogenous and physiologically relevant cardac models is required.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) conducted a case report in Dilated cardiomyopathy (n=1). LMNA c.929A>G (p.Gln310Arg) variant vs. Wild-type LMNA was evaluated on In vitro cellular phenotype. Expression of the LMNA p.Gln310Arg variant in AC16 cells was associated with altered lamin A/C distribution, increased intracellular ROS, reduced mitochondrial membrane potential, and a hypertrophy-like phenotype.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: